Concepedia

The importance of measuring IFNβ bioactivity: Monitoring in MS patients and the effect of anti-IFNβ antibodies

Andrew R. Pachner, Donna Dail, Elena E. Pak, Kavitha Narayan

Journal of Neuroimmunology · 2005 · 72 citations · 34 references

DOI

Concepts

References

34

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

Neurology · 1993 · 2.1K citations

, , +14

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

George C. Ebers · The Lancet · 1998 · 2.1K citations

, , +8

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.

Marc Girard, Pierre Duquette, W. A. Sibley · 1993 · 1.2K citations

, , +10

PRISMS-4: Long-term efficacy of interferon-β-1a in relapsing MS

Neurology · 2001 · 568 citations

, , +17

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS

G. Francis, Richard AC Hughes, John King et al. · DIAL (Catholic University of Leuven) · 2001 · 472 citations

, , +8